Oryzon Genomics SA Sustainability Reports
Oryzon Genomics S.A. is a biopharmaceutical company focused on researching and developing innovative therapies in the field of epigenetics for the treatment of severe diseases.
Sector: Health Care
Country: Spain
Exchange: Madrid Stock Exchange
ISIN: ES0167733015
12 reports from 2015 to 2025
Company Profile
Oryzon Genomics SA
Oryzon Genomics S.A. is a biopharmaceutical company focused on researching and developing innovative therapies in the field of epigenetics for the treatment of severe diseases.
Reports